FDA recall record

CEPHALEXIN Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 recall — FDA D-0178-2021

Failed Impurity/Degradation Specifications

Class IIclassification
D-0178-2021official record ID
Jan 6, 2021report date

Recall record at a glance

Official recordD-0178-2021
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmAscend Laboratories LLC
Report dateJan 6, 2021
Recall initiation dateDec 17, 2020
Quantity29,317 bottles
LocationParsippany, NJ, United States

Official product description

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88

Why the product was recalled

Failed Impurity/Degradation Specifications

Distribution information

Nationwide

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.